Pharmafile Logo

Decideum

Decideum has over 20 years experience in providing nuanced, effective and results-driven HTA and market access support to pharmaceutical clients in the UK and EU.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Niddry Lodge, 51 Holland Street, London, W8 7JB, United Kingdom
020 7368 1611

 Latest Content from PMHub 

Medscape To Bring Leading Cardiology Education to ESC

The Medscape Global team is bringing their leading cardiology education and proven impact to the European Society of Cardiology (ESC) Congress in Madrid for 2025. Powered by enhanced technologies, methodologies,...

Engage Internal Teams Virtually – Engaging Your Advisors Creatively

Boost internal effectiveness! Learn a creative way to use virtual advisory boards to facilitate best practice-sharing with sales representatives and knowledge-sharing with MSLs. This is the key to aligning your...

The Mission to Humanize Healthcare

Medical and scientific innovation are in a fast lane closely pursued by digital advances but their dynamism can mute a vital element of progressive healthcare – patient integration.

Implementation of Cost-Effectiveness Analysis in Japan’s Health Technology Assessment Process

Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health technology assessment (HTA)...

Designing with patients in mind: How to build more inclusive clinical trials

Press Releases | August 4, 2025 | Cuttsy + Cuttsy

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

Three Key Trends Shaping the Future of Clinical Trials

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

Advertising For Women’s Health: Breaking Taboos and Driving Change

Our strategist Stephanie Goley, MSc, PhD takes a fascinating look at how advertising is breaking down stigmas around areas of women's health such as menstruation and menopause - and helping...

Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.